IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $617 | -96.9% | 420 | -94.6% | 0.00% | -100.0% |
Q2 2023 | $19,608 | +103100.0% | 7,812 | -39.7% | 0.00% | 0.0% |
Q1 2023 | $19 | -52.5% | 12,956 | -55.3% | 0.00% | -50.0% |
Q4 2022 | $40 | -99.9% | 28,958 | +97.2% | 0.00% | +100.0% |
Q3 2022 | $46,000 | +58.6% | 14,685 | +71.8% | 0.00% | 0.0% |
Q2 2022 | $29,000 | +163.6% | 8,546 | +741.1% | 0.00% | – |
Q1 2022 | $11,000 | +83.3% | 1,016 | +51.4% | 0.00% | – |
Q4 2021 | $6,000 | -60.0% | 671 | -61.7% | 0.00% | – |
Q3 2021 | $15,000 | -92.6% | 1,751 | -89.4% | 0.00% | -100.0% |
Q2 2021 | $203,000 | +745.8% | 16,565 | +1026.1% | 0.01% | – |
Q1 2021 | $24,000 | -79.7% | 1,471 | -80.9% | 0.00% | -100.0% |
Q4 2020 | $118,000 | +84.4% | 7,698 | +122.9% | 0.00% | +300.0% |
Q3 2020 | $64,000 | +357.1% | 3,454 | +202.7% | 0.00% | 0.0% |
Q2 2020 | $14,000 | +7.7% | 1,141 | -45.7% | 0.00% | 0.0% |
Q1 2020 | $13,000 | 0.0% | 2,100 | +61.5% | 0.00% | 0.0% |
Q4 2019 | $13,000 | +116.7% | 1,300 | +113.1% | 0.00% | – |
Q3 2019 | $6,000 | -81.8% | 610 | -79.0% | 0.00% | -100.0% |
Q2 2019 | $33,000 | – | 2,910 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 1,788,160 | $2,628,595 | 2.41% |
Gratus Capital, LLC | 1,686,455 | $2,479,089 | 0.17% |
INNOVIS ASSET MANAGEMENT LLC | 272,457 | $400,512 | 0.15% |
Parkman Healthcare Partners LLC | 562,506 | $826,884 | 0.15% |
RTW INVESTMENTS, LP | 4,335,255 | $6,372,825 | 0.13% |
Logos Global Management LP | 421,184 | $619,140 | 0.08% |
Ikarian Capital, LLC | 450,000 | $661,501 | 0.08% |
BVF INC/IL | 1,149,425 | $1,689,655 | 0.05% |
Soleus Capital Management, L.P. | 300,000 | $441,000 | 0.04% |
COWEN AND COMPANY, LLC | 317,059 | $466,076 | 0.03% |